Covid-19 vaccine: A shot at redemption for J & J?
J&J, which has vowed to sell the vaccine at cost, won approval Thursday from the European Union for its Covid-19 jab after receiving the green light earlier from regulators in the United States, Canada and South Africa.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: African Health | Biotechnology | Canada Health | COVID-19 | Pharmaceuticals | South Africa Health | USA Health | Vaccines